TVTX — Travere Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1438533 ·
Last close
$59.44
Market Cap
$5.60B
52W High
$68.73
52W Low
$22.06
ADV30
1,436,600
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 169,584,000 | 160,349,000 | 3,954,000 | -34,797,000 | 799,360,000 | 117,735,000 | 774,838,000 |
| Mar 2026 | 127,199,000 | 100,433,000 | -36,915,000 | -37,102,000 | 555,188,000 | 78,362,000 | 456,460,000 |
| Dec 2025 | 129,689,000 | 127,136,000 | -32,428,000 | 2,729,000 | 605,191,000 | 93,035,000 | 490,363,000 |
| Sep 2025 | 164,859,000 | 163,274,000 | 24,931,000 | 25,706,000 | 538,581,000 | 110,930,000 | 465,017,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$92,700,000
Investing CF
$-202,986,000
Financing CF
$153,061,000
CapEx
$-77,536,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.46
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,544,612,000
Inventory
$7,835,000
Receivables
$80,636,000
ST Investments
$371,442,000
EBIT TTM
$-57,593,000
Pretax Income TTM
$-67,074,000
Interest Exp TTM
$9,481,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$591,329,984
EBITDA
$22,913,000
Free Cash Flow
$-18,254,250
Enterprise Value
$6,364,983,808
Total Cash
$489,176,992
Total Debt
$616,905,024
Shares Out
94,261,082
Trailing EPS
$-0.73
Book Value
$1.07
ROE
-236.4%
ROA
-3.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 490,728,000 | -62,824,000 | -25,546,000 | 605,191,000 | 490,363,000 | 114,828,000 | 37,784,000 |
| Dec 2024 | 233,175,000 | -321,389,000 | -321,545,000 | 594,125,000 | 535,048,000 | 59,077,000 | -237,475,000 |
| Dec 2023 | 145,238,000 | -376,744,000 | -111,399,000 | 788,913,000 | 588,103,000 | 200,810,000 | -280,021,000 |
| Dec 2022 | 109,460,000 | -319,813,000 | -278,482,000 | 672,585,000 | 629,734,000 | 42,851,000 | -186,291,000 |
TTM Snapshot
Revenues TTM
$209,800,000
NetIncome TTM
$-14,958,000
OpCashFlow TTM
$0
Assets (Latest)
$605,191,000
Forward EPS
$5.67
Max Pain — expiry 2027-01-15
max pain strike: $30.00 · spot: $59.44 · call oi: 14,336 · put oi: 2,555
Expected Move to 2027-01-15:
±$11.40
(19.18%) —
implied range
$48.04 –
$70.84
· ATM straddle on $60.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | $5.61B | $32.31 | — |
| ORKA | Oruka Therapeutics, Inc. | $5.59B | $84.46 | — |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.82B | $89.70 | — |
| PTCT | PTC THERAPEUTICS, INC. | $5.23B | $62.67 | — |
| LGND | LIGAND PHARMACEUTICALS INC | $6.01B | $301.52 | — |
News headlines (Yahoo Finance, 1h cache)
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental G
2026-09-23 11:00 · Yahoo
Travere Therapeutics (TVTX) Sets CEO Handover For December 2026
2026-09-23 01:13 · Yahoo
Travere Therapeutics Announces Planned Chief Executive Officer Transition
2026-09-21 20:05 · Yahoo
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
2026-09-17 20:30 · Yahoo
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-11 21:00 · Yahoo
Travere Therapeutics' Outlook Brightens As Turnaround Looms
2026-09-08 19:44 · Yahoo
IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'
2026-08-21 17:09 · Yahoo
Three Biotech Stocks Stick Out With Their Stellar Charts
2026-08-21 16:09 · Yahoo
Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline
2026-08-18 10:01 · Yahoo
Travere Therapeutics (TVTX) Q2 2026 Earnings Call Transcript
2026-08-12 00:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.